Laboratorios Farmaceuticos ROVI SA
Laboratorios Farmaceuticos ROVI's GHG Emissions Data Preview
In 2023, Laboratorios Farmaceuticos ROVI completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
However, Laboratorios Farmaceuticos ROVI has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Laboratorios Farmaceuticos ROVI's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Laboratorios Farmaceuticos ROVI amounted to 7,895 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Laboratorios Farmaceuticos ROVI increased by 8.02%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Laboratorios Farmaceuticos ROVI's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Laboratorios Farmaceuticos ROVI's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Laboratorios Farmaceuticos ROVI were 7,859 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Laboratorios Farmaceuticos ROVI reduced its Scope 1 emissions over time?
Since 2021, Laboratorios Farmaceuticos ROVI's Scope 1 emissions have increased by 26.15%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Laboratorios Farmaceuticos ROVI's Scope 1 emissions increased by 17.42%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Laboratorios Farmaceuticos ROVI's Scope 2 emissions?
In 2023, Laboratorios Farmaceuticos ROVI reported Scope 2 greenhouse gas (GHG) emissions of 36 tCOâ‚‚e without specifying the calculation method.
Has Laboratorios Farmaceuticos ROVI reduced its Scope 2 emissions over time?
Since 2021, Laboratorios Farmaceuticos ROVI's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 2,471.43%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Laboratorios Farmaceuticos ROVI's Scope 2 emissions (Unspecified Calculation Method) fell by 94.16% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Laboratorios Farmaceuticos ROVI use for Scope 2 reporting?
In 2023, Laboratorios Farmaceuticos ROVI reported its Scope 2 emissions using an unspecified methodology.
Laboratorios Farmaceuticos ROVI's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Laboratorios Farmaceuticos ROVI's Value Chain Emissions
In 2023, Laboratorios Farmaceuticos ROVI reported 11,059 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2023 disclosure of Laboratorios Farmaceuticos ROVI includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Laboratorios Farmaceuticos ROVI's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Laboratorios Farmaceuticos ROVI's Scope 3 emissions?
In 2023, Laboratorios Farmaceuticos ROVI reported total Scope 3 emissions of 11,059 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Laboratorios Farmaceuticos ROVI's Scope 3 emissions remained relatively stable, indicating that Laboratorios Farmaceuticos ROVI 's emissions have plateaued with no significant change in its value chain footprint.
Insights into Laboratorios Farmaceuticos ROVI's Total Carbon Footprint
In 2023, Laboratorios Farmaceuticos ROVI reported a total carbon footprint of 18,954 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 7.32% increase compared to 2022, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Laboratorios Farmaceuticos ROVI's total carbon footprint was Scope 3 emissions, accounting for 58.35% of the company's total carbon footprint, followed by Scope 1 emissions at 41.46%.